RxDoctor Payments Data

Cristi Williams, NP

Acute Care · Plano, TXNPI 1093904526

Payments from drug & device makers

$2,359in general payments, 2019–2025

Across 128 payments — averaging $18.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$356
  • Merck$318
  • Novartis$316
  • Amgen$272
  • Sanofi-aventis U.S. LLC$151
  • Boehringer Ingelheim$149
  • plus $795 from 19 others

What the payments were for

  • Food & beverage$2,359100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,359 in reported general payments places this provider in the 85th percentile of 2,323 acute care providers in Texas.

See all acute care providers in Texas

Medicare billing

Part B allowed, 2024
$20,140
Medicare patients
213
Services billed
439

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban37$40,769
Repatha SureclickEvolocumab22$20,560
EntrestoSacubitril/Valsartan19$15,009
XareltoRivaroxaban11$11,621
Praluent PenAlirocumab22$10,775
FarxigaDapagliflozin Propanediol11$6,445
Ezetimibe116$1,866
Nifedipine ErNifedipine50$1,526
Atorvastatin Calcium123$1,329
Metoprolol Succinate104$1,205
Rosuvastatin Calcium73$1,079
Isosorbide Mononitrate ErIsosorbide Mononitrate86$870
Losartan Potassium56$738
Amlodipine Besylate78$676
Carvedilol54$321

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$92$40,76937 claims
NovartisEntresto$316$15,00919 claims
Johnson & JohnsonXarelto$54$11,62111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,323 acute care providers in Texas.

Other acute care in Plano

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →